Beta-Cyclodextrin/L-Arginine/Au Nanomotors for Atherosclerosis
Most of the current non-pharmacological treatment strategies for atherosclerosis (AS) suffer from poor penetration into the plaque and only aim
A forum for researchers, students and applicants in the field of cyclodextrin technology
Most of the current non-pharmacological treatment strategies for atherosclerosis (AS) suffer from poor penetration into the plaque and only aim